(PharmaNewsWire.Com, February 20, 2019 ) Antibodies (Ab) are also known as immunoglobulin (Ig). These are the large, Y-shaped protein that are produced primarily by plasma cells present in the blood in response to pathogens such as viruses and bacteria. Antibodies are capable of identifying unique molecules with harmful agents. Antibodies are used in various therapeutic areas as well as in diagnostics of disease indications such as rheumatoid arthritis, non-Hodgkin lymphoma, psoriasis, macular degeneration, asthma, Crohn’s disease, and hypercholesterolemia.
At the same time, introduction of alternative therapeutic drugs is projected to impact the growth of the global antibodies market. Moreover, factors such as risk of side effects related with antibodies and high-cost remain the major growth deterrents of the market. According to the latest report published by Fact.MR, the global antibodies market is expected to surpass a valuation of US$ 3,000 Mn by end of 2022, reflecting a steady CAGR between 2017 and 2022.
The report has also profiled key players operating in the global antibodies market, which include Abcam Plc, A.M.S. Biotechnology (Europe) Limited, Bio-Rad Laboratories, Inc., Cell Signaling Technology, Genscript Biotech Corporation, Sigma Aldrich Corp, Crown Bioscience, Inc., Thermo Fisher Scientific, Inc.
North America at the Forefront of the Global Antibodies Market
Currently, North America dominates the global antibodies market in terms of revenue and trend is projected continue in 2017 and beyond. In addition, the market in the region is expected to increase at a moderate CAGR during the forecast period (2017-2022). Presence of leading market players and existence of a well-established healthcare infrastructure is supporting the growth of the market in the region.
Primary Antibodies to Remain Top Selling Product Type
On the basis of product type, the primary antibodies segment currently accounts for the highest share of the global antibodies market in terms of revenue. Towards the end of forecast period, the segment is expected to reach a valuation in excess of US$ 1,091 Mn, reflecting a steady CAGR. The primary antibodies segment is projected to create an absolute $ opportunity of US$ 168.4 Mn between 2017 and 2022.
1. Global Antibodies Market - Executive Summary
2. Global Antibodies Market Overview 2.1. Introduction 2.1.1. Global Antibodies Market Taxonomy 2.1.2. Global Antibodies Market Definition 2.2. Global Antibodies Market Size (US$ Mn) and Forecast, 2012-2022 2.2.1. Global Antibodies Market Y-o-Y Growth 2.3. Global Antibodies Market Dynamics 2.4. Regulations 2.5. Supply Chain 2.6. Cost Structure 2.7. Average Pricing Analysis 2.8. List of Distributors 2.9. Key Participants Market Presence (Intensity Map) By Region
3. Global Antibodies Market Analysis and Forecast By Product Type 3.1. Global Antibodies Market Size and Forecast By Product Type, 2012-2022 3.1.1. Immune Checkpoint Antibodies Antibodies Market Size and Forecast, 2012-2022 3.1.1.1. Revenue (US$ Mn) Comparison, By Region 3.1.1.2. Market Share Comparison, By Region 3.1.1.3. Y-o-Y growth Comparison, By Region 3.1.2. Epitope Tag Antibodies Antibodies Market Size and Forecast, 2012-2022 3.1.2.1. Revenue (US$ Mn) Comparison, By Region 3.1.2.2. Market Share Comparison, By Region 3.1.2.3. Y-o-Y growth Comparison, By Region 3.1.3. Isotype Control Antibodies Antibodies Market Size and Forecast, 2012-2022 3.1.3.1. Revenue (US$ Mn) Comparison, By Region 3.1.3.2. Market Share Comparison, By Region 3.1.3.3. Y-o-Y growth Comparison, By Region 3.1.4. Primary Antibodies Antibodies Market Size and Forecast, 2012-2022 3.1.4.1. Revenue (US$ Mn) Comparison, By Region 3.1.4.2. Market Share Comparison, By Region 3.1.4.3. Y-o-Y growth Comparison, By Region 3.1.5. Assay Antibodies (includes secondary antibodies) Antibodies Market Size and Forecast, 2012-2022 3.1.5.1. Revenue (US$ Mn) Comparison, By Region 3.1.5.2. Market Share Comparison, By Region 3.1.5.3. Y-o-Y growth Comparison, By Region 3.1.6. Other Antibodies Market Size and Forecast, 2012-2022 3.1.6.1. Revenue (US$ Mn) Comparison, By Region 3.1.6.2. Market Share Comparison, By Region 3.1.6.3. Y-o-Y growth Comparison, By Region
4. Global Antibodies Market Analysis and Forecast By End User 4.1. Global Antibodies Market Size and Forecast By End User, 2012-2022 4.1.1. Biopharmaceutical Companies Antibodies Market Size and Forecast, 2012-2022 4.1.1.1. Revenue (US$ Mn) Comparison, By Region 4.1.1.2. Market Share Comparison, By Region 4.1.1.3. Y-o-Y growth Comparison, By Region 4.1.2. Contract Research Organizations (CROs) Antibodies Market Size and Forecast, 2012-2022 4.1.2.1. Revenue (US$ Mn) Comparison, By Region 4.1.2.2. Market Share Comparison, By Region 4.1.2.3. Y-o-Y growth Comparison, By Region 4.1.3. Academic & Research Institutes Antibodies Market Size and Forecast, 2012-2022 4.1.3.1. Revenue (US$ Mn) Comparison, By Region 4.1.3.2. Market Share Comparison, By Region 4.1.3.3. Y-o-Y growth Comparison, By Region 4.1.4. Forensic Science Laboratories Antibodies Market Size and Forecast, 2012-2022 4.1.4.1. Revenue (US$ Mn) Comparison, By Region 4.1.4.2. Market Share Comparison, By Region 4.1.4.3. Y-o-Y growth Comparison, By Region 4.1.5. Food & Beverage Companies Antibodies Market Size and Forecast, 2012-2022 4.1.5.1. Revenue (US$ Mn) Comparison, By Region 4.1.5.2. Market Share Comparison, By Region 4.1.5.3. Y-o-Y growth Comparison, By Region 4.1.6. Diagnostic Centers Antibodies Market Size and Forecast, 2012-2022 4.1.6.1. Revenue (US$ Mn) Comparison, By Region 4.1.6.2. Market Share Comparison, By Region 4.1.6.3. Y-o-Y growth Comparison, By Region 4.1.7. Others Antibodies Market Size and Forecast, 2012-2022 4.1.7.1. Revenue (US$ Mn) Comparison, By Region 4.1.7.2. Market Share Comparison, By Region 4.1.7.3. Y-o-Y growth Comparison, By Region
5. Global Antibodies Market Analysis and Forecast By Application 5.1. Global Antibodies Market Size and Forecast By Application, 2012-2022 5.1.1. Drug Discovery & Development Antibodies Market Size and Forecast, 2012-2022 5.1.1.1. Revenue (US$ Mn) Comparison, By Region 5.1.1.2. Market Share Comparison, By Region 5.1.1.3. Y-o-Y growth Comparison, By Region 5.1.2. Basic Research Antibodies Market Size and Forecast, 2012-2022 5.1.2.1. Revenue (US$ Mn) Comparison, By Region 5.1.2.2. Market Share Comparison, By Region 5.1.2.3. Y-o-Y growth Comparison, By Region 5.1.3. Toxicity Screening Antibodies Market Size and Forecast, 2012-2022 5.1.3.1. Revenue (US$ Mn) Comparison, By Region 5.1.3.2. Market Share Comparison, By Region 5.1.3.3. Y-o-Y growth Comparison, By Region 5.1.4. Biopharmaceutical Production Antibodies Market Size and Forecast, 2012-2022 5.1.4.1. Revenue (US$ Mn) Comparison, By Region 5.1.4.2. Market Share Comparison, By Region 5.1.4.3. Y-o-Y growth Comparison, By Region 5.1.5. Drug Screening Antibodies Market Size and Forecast, 2012-2022 5.1.5.1. Revenue (US$ Mn) Comparison, By Region 5.1.5.2. Market Share Comparison, By Region 5.1.5.3. Y-o-Y growth Comparison, By Region 5.1.6. Tissue Engineering Antibodies Market Size and Forecast, 2012-2022 5.1.6.1. Revenue (US$ Mn) Comparison, By Region 5.1.6.2. Market Share Comparison, By Region 5.1.6.3. Y-o-Y growth Comparison, By Region 5.1.7. Forensic Testing Antibodies Market Size and Forecast, 2012-2022 5.1.7.1. Revenue (US$ Mn) Comparison, By Region 5.1.7.2. Market Share Comparison, By Region 5.1.7.3. Y-o-Y growth Comparison, By Region
6. Global Antibodies Market Analysis and Forecast By Region 6.1. Global Antibodies Market Size and Forecast, 2012-2022 6.1.1. North America Antibodies Market Size and Forecast, 2012-2022 6.1.1.1. Revenue (US$ Mn) Comparison, By Product Type 6.1.1.2. Revenue (US$ Mn) Comparison, By End User 6.1.1.3. Revenue (US$ Mn) Comparison, By Application 6.1.2. Latin America Antibodies Market Size and Forecast, 2012-2022 6.1.2.1. Revenue (US$ Mn) Comparison, By Product Type 6.1.2.2. Revenue (US$ Mn) Comparison, By End User 6.1.2.3. Revenue (US$ Mn) Comparison, By Application 6.1.3. Europe Antibodies Market Size and Forecast, 2012-2022 6.1.3.1. Revenue (US$ Mn) Comparison, By Product Type 6.1.3.2. Revenue (US$ Mn) Comparison, By End User 6.1.3.3. Revenue (US$ Mn) Comparison, By Application 6.1.4. Japan Antibodies Market Size and Forecast, 2012-2022 6.1.4.1. Revenue (US$ Mn) Comparison, By Product Type 6.1.4.2. Revenue (US$ Mn) Comparison, By End User 6.1.4.3. Revenue (US$ Mn) Comparison, By Application 6.1.5. APEJ Antibodies Market Size and Forecast, 2012-2022 6.1.5.1. Revenue (US$ Mn) Comparison, By Product Type 6.1.5.2. Revenue (US$ Mn) Comparison, By End User 6.1.5.3. Revenue (US$ Mn) Comparison, By Application 6.1.6. MEA Antibodies Market Size and Forecast, 2012-2022 6.1.6.1. Revenue (US$ Mn) Comparison, By Product Type 6.1.6.2. Revenue (US$ Mn) Comparison, By End User 6.1.6.3. Revenue (US$ Mn) Comparison, By Application
7. North America Antibodies Market Analysis and Forecast, By Country, 2012-2022 7.1. US Antibodies Market Size and Forecast, 2012-2022 7.1.1. Revenue (US$ Mn) Comparison, By Product Type 7.1.2. Revenue (US$ Mn) Comparison, By End User 7.1.3. Revenue (US$ Mn) Comparison, By Application 7.2. Canada Antibodies Market Size and Forecast, 2012-2022 7.2.1. Revenue (US$ Mn) Comparison, By Product Type 7.2.2. Revenue (US$ Mn) Comparison, By End User 7.2.3. Revenue (US$ Mn) Comparison, By Application
8. Latin America Antibodies Market Analysis and Forecast, By Country, 2012-2022 8.1. Brazil Antibodies Market Size and Forecast, 2012-2022 8.1.1. Revenue (US$ Mn) Comparison, By Product Type 8.1.2. Revenue (US$ Mn) Comparison, By End User 8.1.3. Revenue (US$ Mn) Comparison, By Application 8.2. Mexico Antibodies Market Size and Forecast, 2012-2022 8.2.1. Revenue (US$ Mn) Comparison, By Product Type 8.2.2. Revenue (US$ Mn) Comparison, By End User 8.2.3. Revenue (US$ Mn) Comparison, By Application 8.3. Argentina Antibodies Market Size and Forecast, 2012-2022 8.3.1. Revenue (US$ Mn) Comparison, By Product Type 8.3.2. Revenue (US$ Mn) Comparison, By End User 8.3.3. Revenue (US$ Mn) Comparison, By Application
9. Europe Antibodies Market Analysis and Forecast, By Country, 2012-2022 9.1. Germany Antibodies Market Size and Forecast, 2012-2022 9.1.1. Revenue (US$ Mn) Comparison, By Product Type 9.1.2. Revenue (US$ Mn) Comparison, By End User 9.1.3. Revenue (US$ Mn) Comparison, By Application 9.2. UK Antibodies Market Size and Forecast, 2012-2022 9.2.1. Revenue (US$ Mn) Comparison, By Product Type 9.2.2. Revenue (US$ Mn) Comparison, By End User 9.2.3. Revenue (US$ Mn) Comparison, By Application 9.3. France Antibodies Market Size and Forecast, 2012-2022 9.3.1. Revenue (US$ Mn) Comparison, By Product Type 9.3.2. Revenue (US$ Mn) Comparison, By End User 9.3.3. Revenue (US$ Mn) Comparison, By Application 9.4. Spain Antibodies Market Size and Forecast, 2012-2022 9.4.1. Revenue (US$ Mn) Comparison, By Product Type 9.4.2. Revenue (US$ Mn) Comparison, By End User 9.4.3. Revenue (US$ Mn) Comparison, By Application 9.5. Italy Antibodies Market Size and Forecast, 2012-2022 9.5.1. Revenue (US$ Mn) Comparison, By Product Type 9.5.2. Revenue (US$ Mn) Comparison, By End User 9.5.3. Revenue (US$ Mn) Comparison, By Application 9.6. Nordic Antibodies Market Size and Forecast, 2012-2022 9.6.1. Revenue (US$ Mn) Comparison, By Product Type 9.6.2. Revenue (US$ Mn) Comparison, By End User 9.6.3. Revenue (US$ Mn) Comparison, By Application
10. Japan Antibodies Market Analysis and Forecast, By Country, 2012-2022 10.1. Japan Antibodies Market Size and Forecast, 2012-2022 10.1.1. Revenue (US$ Mn) Comparison, By Product Type 10.1.2. Revenue (US$ Mn) Comparison, By End User 10.1.3. Revenue (US$ Mn) Comparison, By Application
About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.
Contact Us Rohit Bhisey Fact.MR 11140 Rockville Pike Suite 400 Rockville, MD 20852 United States Email: sales@factmr.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
